Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
芬维A胺、托珠单抗和瑞帕利辛对口腔鳞状细胞癌干细胞特性进行多方面破坏：对三级化学预防的影响
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-19-0361
Susan R Mallery #, Daren Wang #, Brian Santiago, Ping Pei, Caroline Bissonnette, Jayanetti Asiri Jayawardena, Steven P Schwendeman, Richard Spinney, James Lang
